Associate Professor in the Surgery Department at Massachusetts General Hospital, Harvard Medical School, and Shriners Hospital for Children, Boston
Dr. Irimia is a bioengineer, a researcher in the areas of microfluidics, and a medical doctor by training. His work melds engineering and medicine, towards the development of novel microfluidic tools for a variety of applications, from the early diagnostic of sepsis and the study of neutrophil swarming to the stimulation of neuronal migration and quantification of axonal transport. Dr. Irimia has published more than 100 journal articles in top-tier journals such as Nature Biomedical Engineering, Nature Materials, Nature Communications, the Proceedings of the National Academy of Sciences. He was recently awarded the “Pioneers of Miniaturization” prize from the Chemical and Biological Microsystems Society for his work on microfluidic devices for studying neutrophils in inflammation, infections, and sepsis. He is the organizer of the Dicty World Race, a global effort aimed at encouraging biologists to integrate microfluidic tools in cell chemotaxis research. He is now collaborating with outstanding neurobiologists at the Massachusetts General Hospital to bring new technologies and better in vitro assays to the study of Alzheimer’s Disease and its underlying cellular and molecular mechanisms.